FHTX vs PG · rev $22.6M vs P/E 25, rev $84.28B
Foghorn Therapeutics Inc (FHTX) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Foghorn Therapeutics Inc (FHTX) is a biotechnology company listed on NASDAQ.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported FHTX revenue for 2024-12-31 was $22.6M. Net income was -$86.6M. Revenue was down 33.8% from 2023-12-31 to 2024-12-31. FHTX currently screens at market cap $237.8M.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
FHTX currently screens at market cap $237.8M. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the FHTX and PG stock pages for the full models.
Not investment advice.